IP Library Granted Patent US 10,323,272
Granted Patent B1
US 10,323,272 · App. 16/053,138 · Granted Jun 18, 2019

Nucleic acid probes for in situ hybridization

Inventors: Elazar Rabbani (New York, NY); Jack Coleman (East Northport, NY); Maurizio Mauro (Long Island City, NY)
Assignee: Enzo Biochem, Inc.
C12Q1/6841C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,323,272
App. No.
16/053,138
Granted
Jun 18, 2019
Kind
B1
Abstract

The invention provides nucleic acid hybridization probes having improved detectability that include a plurality of first segments consecutively complementary to a target nucleic acid sequence and, between neighboring first segments, a nucleic acid spacer segment which is not complementary to the target nucleic acid sequence and which may include labeled nucleic acid residues. Also provided by the invention are methods for making the probes, methods for using the probes, and compositions of matter that include the probes hybridized to target nucleic acid molecules.

Claims (29)

1. A method for preparing a nucleic acid hybridization probe composition for a nucleic acid target of interest, comprising the steps of:

providing an in vitro mixture of

(a) a DNA construct comprising an RNA promoter operably linked to a template DNA sequence, wherein the template sequence encodes a non-naturally occurring linear nucleic acid molecule having a 5′ end and a 3′ end and comprising

a series of first nucleic acid segments consecutively complementary to a preselected nucleic acid target sequence, and

between each adjacent pair of first nucleic acid segments, a spacer nucleic acid segment,

wherein the spacer segments are not substantially complementary to the preselected nucleic acid target sequence, and

wherein the spacer segments are not substantially complementary to the first segments,

(b) a mixture of different ribonucleoside triphosphates wherein at least some of said ribonucleoside triphosphates are chemically labeled;

(c) an RNA polymerase capable of transcribing an RNA molecule comprising residues of the chemically labeled ribonucleoside triphosphates from the template under control of the promoter;

incubating said mixture under conditions permissive for transcription of the RNA molecule by the RNA polymerase, wherein said RNA molecule is thereby transcribed in quantity; and

partially fragmenting the quantity of RNA molecule obtained by transcription in the incubating step to obtain a fragmented nucleic acid hybridization probe composition.

2. The method of claim 1 , wherein the chemically labeled ribonucleoside triphosphates comprise a hapten label.

3. The method of claim 2 , wherein the hapten label is selected from the group consisting of biotin and digoxigenin.

4. The method of claim 1 , wherein the chemically labeled ribonucleoside triphosphates comprise a fluorescent label.

5. The method of claim 1 , wherein the chemically labeled ribonucleoside triphosphates comprise an allyl amine group label.

6. A method for preparing a nucleic acid hybridization probe composition for a nucleic acid target of interest, comprising the steps of:

providing an in vitro mixture of

(a) a nucleic acid template molecule, wherein the template sequence encodes a non-naturally occurring linear nucleic acid molecule having a 5′ end and a 3′ end and including

a series of first nucleic acid segments consecutively complementary to a preselected nucleic acid target sequence, and

between each adjacent pair of first nucleic acid segments, a spacer nucleic acid segment,

wherein the spacer segments are not substantially complementary to the preselected nucleic acid target sequence;

(b) a template-directed nucleic acid polymerase capable of synthesizing a nucleic acid molecule comprising residues of chemically labeled nucleoside triphosphates and complementary to at least part of the template using the template molecule, and

(c) a mixture of different nucleoside triphosphates wherein at least some of said nucleoside triphosphates are chemically labeled;

incubating said mixture under conditions permissive for template-directed nucleic acid synthesis by the polymerase, wherein said nucleic acid molecule including residues of the chemically labeled nucleoside triphosphates and complementary to at least part of the template is thereby synthesized in quantity by the polymerase using the template; and

partially fragmenting the quantity of the synthesized nucleic acid molecule comprising residues of chemically labeled nucleoside triphosphates and complementary to at least part of the template to obtain a fragmented nucleic acid hybridization probe composition.

7. The method of claim 6 , wherein the chemically labeled ribonucleoside triphosphates comprise a hapten label.

8. The method of claim 7 , wherein the hapten label is selected from the group consisting of biotin and digoxigenin.

9. The method of claim 6 , wherein the chemically labeled ribonucleoside triphosphates comprise a fluorescent label.

10. The method of claim 6 , wherein the chemically labeled ribonucleoside triphosphates comprise an allyl amine group label.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: RABBANI, ELAZAR; COLEMAN, JACK; MAURO, MAURIZIO; DONEGAN, JAMES J.
To: ENZO BIOCHEM, INC.
Reel/Frame 046638/0751 →
Continuity (1)
Provisional Application 62624249 · Jan 31, 2018
Cited By (13)
US 12,252,740 US 12,258,623 US 12,286,666 US 12,286,667 US 12,365,936 US 12,391,988 US 12,421,541 US 12,486,532 US 12,510,744 US 12,529,093 US 12,577,611 US 12,646,340 US 12,655,474